CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study

Availability of COVID-19 mRNA vaccine for patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg) raises the question of whether COVID-19 mRNA vaccine influences disease activity or IVIg-mediated immunomodulation in CIDP. In this explorat...

Descripción completa

Detalles Bibliográficos
Autores principales: Svačina, Martin K. R., Meißner, Anika, Schweitzer, Finja, Sprenger-Svačina, Alina, Klein, Ines, Wüstenberg, Hauke, Kohle, Felix, Walter, Helene L., Schroeter, Michael, Lehmann, Helmar C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018581/
https://www.ncbi.nlm.nih.gov/pubmed/36929282
http://dx.doi.org/10.1007/s11481-023-10058-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018581/
https://www.ncbi.nlm.nih.gov/pubmed/36929282
http://dx.doi.org/10.1007/s11481-023-10058-x

Ejemplares similares